Article Information
PubMed
Published By
History
- Received March 12, 2006
- Revision received May 31, 2006
- Accepted May 31, 2006
- First published July 5, 2006.
- Version of record published July 5, 2006.
Copyright & Usage
Copyright © 2006 Society for Neuroscience 0270-6474/06/267281-12$15.00/0
Author Information
- Xin Fang1,
- Laiche Djouhri1,
- Simon McMullan1,
- Carol Berry1,
- Stephen G. Waxman2,
- Kenji Okuse3, and
- Sally N. Lawson1
- 1Department of Physiology, Medical School, Bristol University, Bristol BS8 1TD, United Kingdom, 2Department of Neurology, Yale University School of Medicine, New Haven, Connecticut 06510, and 3Division of Cell and Molecular Biology, Faculty of Life Sciences, Imperial College London, London SW7 2AZ, United Kingdom
Author contributions
Disclosures
- Received March 12, 2006.
- Revision received May 31, 2006.
- Accepted May 31, 2006.
-
This work was supported by The Biotechnology and Biological Sciences Research Council (United Kingdom) and Wellcome United Kingdom grants to S.N.L. and by a Bristol University Studentship to X.F. We thank L. F. Reichardt for the gift of anti-trkA antibody, J. Wood and K. Okuse for the anti-Nav1.8 antibody, and B. Carruthers for technical assistance.
-
X. Fang's present address: Department of Biological Sciences, University of Warwick, Coventry CV4 7AL, UK.
-
S. McMullan's present address: Hypertension and Stroke Research Laboratory, University of Sydney, Royal North Shore Hospital, St Leonards, Sydney 2065, Australia.
- Correspondence should be addressed to Prof. Sally N. Lawson, Department of Physiology, Medical School, University of Bristol, University Walk, Bristol BS8 1TD, UK. Email: Sally.Lawson{at}bristol.ac.uk
Online Impact
